Gene · 80149
Papers1,426
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,426
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The crucial regulatory role of type I interferon in inflammatory diseases. | Cell Biosci | 2023 | 38124132 | PubTator, text mining | PubMed |
| MicroRNAs as Potential Biomarkers of Environmental Exposure to Polycyclic Aromatic Hydrocarbons and Their Link with Inflammation and Lung Cancer. | Int J Mol Sci | 2023 | 38069307 | PubTator, text mining | PubMed |
| Kinetics and Role of Pancreatic Stone Protein and Midregional Proadrenomedullin as Predictors of Sepsis and Bacteremia in Children with Hematological Malignancies. | Mediterr J Hematol Infect Dis | 2023 | 38028393 | PubTator, text mining | PubMed |
| Co-evolution of SARS-CoV-2 variants and host immune response trajectories underlie COVID-19 pandemic to epidemic transition. | iScience | 2023 | 38025778 | PubTator, text mining | PubMed |
| Current trends of clinical trials involving CRISPR/Cas systems. | Front Med (Lausanne) | 2023 | 38020120 | PubTator, text mining | PubMed |
| Mild heat treatment in vitro potentiates human adipose stem cells: delayed aging and improved quality for long term culture. | Biomater Res | 2023 | 38008757 | PubTator, text mining | PubMed |
| Involvement of the OTUB1-YAP1 axis in driving malignant behaviors of head and neck squamous cell carcinoma. | Cancer Med | 2023 | 37986681 | PubTator, text mining | PubMed |
| From Fruit Waste to Medical Insight: The Comprehensive Role of Watermelon Rind Extract on Renal Adenocarcinoma Cellular and Transcriptomic Dynamics. | Int J Mol Sci | 2023 | 37958599 | PubTator, text mining | PubMed |
| Central administration of Dapagliflozin alleviates a hypothalamic neuroinflammatory signature and changing tubular lipid metabolism in type 2 diabetic nephropathy by upregulating MCPIP1. | Biomed Pharmacother | 2023 | 37931516 | PubTator, text mining | PubMed |
| TTC13 expression and STAT3 activation may form a positive feedback loop to promote ccRCC progression. | PeerJ | 2023 | 37927783 | PubTator, text mining | PubMed |
| p38 MAPK signaling in chronic obstructive pulmonary disease pathogenesis and inhibitor therapeutics. | Cell Commun Signal | 2023 | 37919729 | PubTator, text mining | PubMed |
| Serum miRNA-21, miRNA-146a and plasma cell free DNA as novel biomarkers for assessing systemic lupus erythematosus activity. | Mol Biol Rep | 2023 | 37904010 | PubTator, text mining | PubMed |
| Niclosamide as a chemical probe for analyzing SARS-CoV-2 modulation of host cell lipid metabolism. | Front Microbiol | 2023 | 37901834 | PubTator, text mining | PubMed |
| RNA modification in cardiovascular disease: implications for therapeutic interventions. | Signal Transduct Target Ther | 2023 | 37884527 | PubTator, text mining | PubMed |
| Molecular mechanisms in colitis-associated colorectal cancer. | Oncogenesis | 2023 | 37884500 | PubTator, text mining | PubMed |
| Toll-like receptor 9 signaling in chronic lymphocytic leukemia cell lines. | FEBS Open Bio | 2023 | 37881888 | PubTator, text mining | PubMed |
| Advancements in CRISPR screens for the development of cancer immunotherapy strategies. | Mol Ther Oncolytics | 2023 | 37876793 | PubTator, text mining | PubMed |
| Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trial. | Nat Commun | 2023 | 37875494 | PubTator, text mining | PubMed |
| Red Blood Cell-Derived Extracellular Vesicles Display Endogenous Antiviral Effects and Enhance the Efficacy of Antiviral Oligonucleotide Therapy. | ACS Nano | 2023 | 37852618 | PubTator, text mining | PubMed |
| Predicting maximum temperatures over India 10-days ahead using machine learning models. | Sci Rep | 2023 | 37821672 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/80149/papers?page=7